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Abstract
Object Hepatic lipid accumulation is associated with
nonalcoholic fatty liver disease, and the metabolic syn-
drome constitutes an increasing medical problem. In vivo
proton magnetic resonance spectroscopy (1H MRS) allows
the assessment of hepatic lipid levels noninvasively and
also yields information on the fat composition due to its
high spectral resolution.
Materials and methods We applied 1H MRS at 9.4T to
study lipid content and composition in eight leptin-defi-
cient ob/ob mice as a model of obesity and in four lean
ob/? control mice at 24 weeks of age. PRESS sequence
was used. For accurate estimation of signal intensity, dif-
ferences in relaxation behavior of individual signals were
accounted for each mouse individually. Also, in order
to minimize spectral degrading due to motion artifacts,
respiration gating was applied.
Results Significant differences between ob/ob and ob/?
control mice were found in both lipid content and com-
position. The mean chain length was found to be signifi-
cantly longer in ob/ob mice with a higher fraction of
monounsaturated lipids.
Conclusion 1H MRS enables accurate assessment in
hepatic lipids in mice, which is attractive for mechanistic
studies of altered metabolism given the large number of
genetically engineered mouse models available.
Keywords Hepatic steatosis  Mouse  Obesity 
Magnetic resonance spectroscopy (MRS)
Abbreviations
CRLB The Cramer–Rao lower bound
fMUL Fraction of monounsaturated lipids
FOV Field-of-view
fPUL Fraction of polyunsaturated lipids
fSL Fraction of saturated lipids
fUL Fraction of unsaturated lipids
fLM Fractional lipid mass
MCL Mean chain length
NA Number of averages
ob/ob Lepob/Lepob
ob/? Lepob/?
SL Saturated lipid component
TG Triglyceride
ULtotal Total unsaturated lipid component
Introduction
Hepatic steatosis, characterized by the accumulation of
lipid droplets within hepatocytes, is of increasing preva-
lence among the population. Lipid accumulation in the
liver is associated with nonalcoholic fatty liver disease,
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obesity and/or type 2 diabetes [1–3]. An accurate and
preferentially non-invasive method for detection and stag-
ing hepatic lipid deposition is important for diagnosis and
therapy management.
In the last few decades, many methods have been applied
for quantification of lipid composition, including gas chro-
matography, mass spectrometry, 1H and 13C nuclear mag-
netic resonance (NMR). Both gas chromatography,
considered as the golden standard, and mass spectrometry
require tissue samples [4–6]. Magnetic resonance spectros-
copy (MRS) is a quantitative technique, and due to its non-
invasive nature can facilitate longitudinal studies. Due to the
high chemical specificity provided by MRS, detailed infor-
mation on the lipid composition can be obtained [7–11]. In
validation studies using different oil samples, good agree-
ment between the lipid composition as derived from 1H and
13C MRS readouts and results derived from gas chroma-
tography analysis has been obtained [9]. In vitro and in vivo
1H MRS were applied to assess the lipid composition in
white adipose tissue, brown adipose tissue, tumor, bone
marrow, and subcutaneous fat of humans [7, 10, 12–18] and
the in vivo spectroscopic results were compared with data
from biopsy samples. Similar 1H MRS has been carried out to
assess triacylglycerol and fatty acids in livers in humans and
rodents both in vivo and ex vivo [19–26].
The objective of our study was to compare the lipid
composition in liver of ob/ob and ob/? control mice. Ob/ob
mice are widely used as model of obesity and type 2 diabetes.
They are characterized by leptin deficiency, which leads to
increased food intake and reduced energy expenditure; in
addition, ob/ob mice display a slightly increased feed effi-
ciency (increased body weight gain for identical caloric
intake as compared to ob/? controls) [3, 22, 27, 28]. This
metabolic condition causes a redistribution of fat storage
from fat pads to non-adipose tissue such as liver, skeletal
muscle, heart and pancreas. This increased uptake and storage
of lipids in non-adipose tissues is thought to induce cell
damage and apoptosis [29, 30]. For example in liver, which
plays a unique role in controlling carbohydrate and lipid
homeostasis, impairment of mitochondria has been reported
[31]. The resulting liver dysfunction has been shown to cor-
relate not only with the total amount of lipids stored, but also
with their composition, in particular with factors such as the
chain length and the degree of unsaturation [32, 33]. 1H MRS
should provide this information in a non-invasive manner.
Materials and methods
Animals and experimental protocol
Twelve male mice were used: eight ob/ob and four age-
matched ob/? controls (Jackson Lab, Charles River
Laboratories, Research Models and Services, Germany
GmbH) at 24 weeks of age. Prior to the MR examinations
the body weight of the animals was determined (61.7 ±
1.8 g in ob/ob vs. 34.9 ± 1.5 g in ob/?). For MRS studies
the mice were initially anesthetized using 3% isoflurane,
and anesthesia levels were reduced to 1.5–2.25% in a
combination of oxygen-air mixture (1/2.5) during the
course of the experiments administered via face mask. The
mice were positioned prone on a surface coil with the liver
on top of the coil center. For physiological monitoring a
ML880 16/30 Powerlab system (AD Instruments, Spech-
bach, Germany) was used. The body temperature was
monitored and controlled with water heating. The respira-
tion signal was monitored as well using a balloon sensor,
and used for respiration gating. The mice were housed with
free access to standard chow and water. All animal
experiments were performed in strict adherence to the
Swiss Law for Animal Protection.
MRS experiment
In vivo MRS measurements were performed using a Bruker
BioSpec 94/30 (Bruker BioSpin GmbH, Ettlingen, Ger-
many) system equipped with 9.4 T magnet with 30 cm bore
diameter. A birdcage volume resonator (70 mm inner
diameter) and a surface coil (phased array for ob/ob, single
loop surface coil for ob/?, due to differences in body sizes)
were used for transmission and signal reception respec-
tively. The gradient system was capable of switching
400 mT/m at a minimal rise time of 80 ls. An IntraGate
(Bruker BioSpin GmbH, Ettlingen, Germany) pulse
sequence was used for anatomical reference images with a
field-of-view (FOV) = 40 9 40 mm2 (ob/ob) and 30 9 30
mm2 (ob/?), matrix dimension = 256 9 128, TR = 1.5 s,
TE = 8 ms, and RARE factor = 8. Respiratory-gating was
implemented for motion correction. The volume of interest
of the subsequent proton spectroscopy was carefully
planned on these images to avoid contributions from
obvious blood vessels and subcutaneous fat. Single-voxel
localized 1H MR spectra were acquired using the PRESS
sequence with additional outer volume suppression with
the following parameters: voxel volume 3 9 3 9 3 mm3,
repetition time TR = 6,000 ms, echo times TE = 12, 18,
24, 30 ms, band width = 4,006 Hz, number of sampling
points = 2,048, acquisition time = 511 ms, number of
averages (NA) = 40 (ob/ob) and 100 (ob/?). Due to res-
piration gating, the actual scan time was longer than the
scan time calculated by the system. This deviation was
minimized by adjusting the duration of the respiration
cycle to around 0.5–1 s. For water suppression the VAPOR
sequence was used. An unsuppressed spectrum was
recorded within the same voxel with NA = 40 (ob/ob) and
NA = 10 (ob/?), yielding the water reference signal. For
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correcting the measured signal intensities for T2 effects, the
T2 relaxation time was derived from measurements with
TR = 6,000 ms, and different echo times TE = 12, 18, 24,
and 30 ms and T2 relaxation times were determined for
individual spectral peaks. This was required for accurate
quantification of hepatic lipid composition.
Analysis of MRS data
All spectroscopy data were processed using LCModel
(Version 6.2-1Q, Stephen Provencher, Oakville, ON,
Canada). Nine lipid signals were identified in our murine
liver 1H MRS spectra. Peak assignments were based on
published data [20] and are summarized in Table 1 [10, 11,
13, 18], which is included to assist the reader. Prior to
quantification, T2 values for individual resonances were
derived by single-exponential fitting of the signal intensi-
ties obtained for the different echo times TEi, I(TEi) =
I(0) 9 exp(-TEi/T2) yielding corrected peak intensities
I(0) for individual peaks of each mouse, where I(TEi) rep-
resents the measured intensity for an echo time TEi. No
correction for T1, since for a TR of 6 s all resonances except
for water can be assumed to be almost fully relaxed [13,
34]. Lip41 and Lip43 from ob/? control mice were
excluded for further quantification, since the spectral
region between 3.6 and 5.0 ppm was cut in LCModel due
to the interference of the residual water signal.
From the intensity of the nine lipid signals normalized to
the number of protons contributing to the signal and the
water signal intensity, a number of parameters were
derived:
(a) The lipid mass and the fractional lipid mass (fLM): The
main contributors to the 1H MR spectrum are protons of
water, mono-, di- and triglycerides, phospholipids and
free fatty acid, as well as a small amount of cholesterol
and cholesterol ester [12, 20, 35]. Contributions from
phospholipids can be neglected due to restricted
mobility of these membrane lipids giving rise to broad
lines [12]. Hence the lipid mass may be estimated from
the weighted sum of all (nine) lipid signals with
weighting factors 13 accounting for the mass of
a =CH– group (Lip52&53), 14 for –CH2– (Lip13,
Lip16, Lip21, Lip23, Lip28, Lip41, Lip43) and 15 for
–CH3 group (Lip09). We assume one –CH3 group
per lipid molecule. Correspondingly the lipid mass may
be estimated as:
Lipid mass ¼ 1
2
 ðLip13 þ Lip16 þ Lip21 þ Lip23
þ Lip28 þ Lip41 þ Lip43Þ  14
þ ðLip52&53Þ  13 þ 1
3
 ðLip09Þ
 15 þ 1
3
 ðLip09Þ  12
þ 2
3
 ðLip09Þ  16 ð1Þ
with the ratios normalizing for the number of protons
contributing to the signal. The last two terms in Eq. 1
include contributions for one carbonyl carbon (mass
12) and of two oxygen atoms (mass 16) per acid chain.
The fLM is obtained as the mass ratio of the lipid
mass divided by the sum of lipid plus water mass;
hence
fLM ¼ lipid mass
lipid mass þ 1
2
 Iwater  18
ð2Þ
Iwater is the intensity of water signal, the factor 1/2
accounts for the 2 protons contributing to the water
signal and 18 is molecular weight of water.
In ob/? mice, the peak intensities of Lip41 and Lip43
were not included in the analysis due to interference
of the residual water signal. Hence, fLM does not
include the contribution of the carbon from these two
structures, which lead to a slight underestimation of
the lipid mass and fLM for ob/? mice.
(b) We define the saturated lipid component (SL) as the
averaged number of –CH2– groups (Lip13) per fatty
acid chain, which is obtained by normalization with
Lip09 signal intensity as there is only one –CH3 group
per lipid chain. We used Lip09 instead of Lip16 or
Lip23 for the quantification of number of chains,
since the Lip09 resonance can be better separated
from neighboring peaks leading to more reliable
quantification results. Accordingly we obtain
SL ¼ 3
2
 Lip13
Lip09
: ð3Þ
(c) The total unsaturated lipid component (ULtotal) can be
defined as the average number of carbon double bonds
per fatty acid chain, i.e.
Table 1 Nine different peaks in proton magnetic resonance spectra
obtained from liver assigned to different 1H positions in lipids
Peak Chemical
shift (ppm)
Lipids-associated
1H of the spectra
Lip09 0.90 CH3–(CH2)n–
Lip13 1.30 –(CH2)n–
Lip16 1.60 –CH2–O–CO–CH2–CH2–
Lip21 2.03 –CH2–CH2–CH=CH–
Lip23 2.25 –CH2–O–CO–CH2–CH2–
Lip28 2.76 –CH=CH–CH2–CH=CH–
Lip41 4.09 –CH2–O–C(O)–CH2–CH2–
Lip43 4.28 –CH2–O–C(O)–CH2–CH2–
Lip52&53 5.32 –CH=CH– and [CH–CH2–
O–C(O)–CH2–CH2–
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ULtotal ¼ 3
2
 Lip52&53
Lip09
: ð4Þ
The peak Lip52&53 contains contributions from both
mono- and polyunsaturated lipids as well as the signal
from glycerol [13], but our spectral resolution is not
high enough to distinguish the various resonances.
The relationship of Lip52&53  1
9
Lip09 was applied
to exclude the contribution from glycerol in previous
work by Giarola [36]. This is correct with the
assumption that there is only triglyceride in hepatic
lipids, which is not applicable for our study. The
factor 2 in the denominator accounts for the fact that
ULtotal accounts for the number of double bonds and
not the number of =CH– groups.
(d) The fraction of unsaturated lipids (fUL) is the average
percentage of fatty acid chains with double carbon
bond structure, including mono- and polyunsaturated
fatty acids.
fUL ¼ 3
4
 Lip21
Lip09
ð5Þ
The factor 1/4 accounts for the fact that adjacent to
both single and double bonds there are two methylen
groups with two protons each. The fraction of
saturated lipids (fSL) is the percentage of fatty acid
chain without carbon double bond, i.e.
fSL ¼ 1  fUL: ð6Þ
The fraction of polyunsaturated lipids (fPUL) is the
percentage of fatty acid chains with multiple double
bonds, i.e.
fPUL ¼ 3
2
 Lip28
Lip09
ð7Þ
with the factor 1/2 accounting for the methylene
group between two double bonds. The fraction of
monounsaturated lipids (fMUL), i.e. the percentage of
fatty acid chains comprising a single carbon double
bond then becomes
fMUL ¼ fUL  fPUL: ð8Þ
(e) The mean chain length (MCL) can be estimated as:
where the term 1 accounts for one carbonyl group per
chain.
Statistical analysis
All results are presented as mean ± SE. For statistical
analysis OriginPro 8.1 (OriginLab, Northampton, MA,
USA) was used. Data (ob/ob vs. ob/?) were analyzed using
the one way ANOVA test. The level of significance was set
as a = 0.05.
Results
Cross-sectional MR images through the abdomen of ob/ob
and ob/? control mice reveal enlarged subcutaneous fat
layers and enlarged liver volumes in ob/ob compared to the
corresponding ob/? control mice (Fig. 1). The localized in
vivo MR spectroscopy of ob/ob and ob/? mice at 9.4T
typically showed nine lipid resonances, which were suffi-
ciently resolved for quantification (Fig. 1) with the peak
assignment given in Table 1.
The magnetic field homogeneity with a full width at half
maximum of the water resonance of 58.1 ± 5.7 Hz and
50.9 ± 1.1 Hz for ob/ob and ob/? control mice, respec-
tively, was sufficient to clearly identify all of the nine lipid
resonances. However, the large amount of accumulated fat
in the liver of ob/ob mice affects local magnetic suscepti-
bility, which may explain the slightly broader line width of
the water peak.
Water suppression was not required for the analysis of
lipid composition in the liver of ob/ob mice, since lipid
signals were of comparable intensity as the water signal. In
fact, water suppression was found, at least in part, to sup-
press the lipid resonances close to 4.65 ppm, resulting in a
reduction of the intensity of peak Lip52&53 by 14%
compared to the spectrum without water suppression.
However, water suppression was required when studying
ob/? mice, since the relatively weak lipid resonances only
became clearly distinguishable when suppressing the large
water peak, which resulted in spectral distortions close to
the water resonance frequency. For the sake of an accurate
comparison of the quantitative results obtained for the two
mouse lines tested, we have applied water suppression in
all measurements. The LCModel could fit all nine different
MCL ¼
1
3
 Lip09 þ 1
2
 ðLip13 þ Lip16 þ Lip21 þ Lip23 þ Lip28Þ þ Lip52&53
1
3
 Lip09 þ 1; ð9Þ
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lipid peaks accurately yielding CRLB lower than 20% for
all peaks included.
The comparison of T2 relaxation times for each lipid
signal of ob/ob and ob/? mice (Table 2) revealed some
statistically significant differences. The T2 value of water
was found to be shorter in ob/ob compared to ob/? mice
(11.9 ± 1.0 ms vs. 14.3 ± 0.3 ms), while the T2 value of
Lip09 was significantly longer in ob/ob mice compared to
ob/? controls (42.1 ± 3.2 ms vs. 25.3 ± 2.8 ms). We did
not observe any statistically significant differences in the
T2 values for any of the other lipid resonances. Because
relaxation times T2 were comparable to the TE values used
in the PRESS sequence, effects of differences in T2
relaxation had to be accounted for in the quantitative
analysis of the signals.
The T2 corrected signal intensities were scaled according
to the number of protons contributing to each resonance peak.
The peak intensities (the averaged intensity relative to the
water signal is listed in Table 2) were used to derive values
characterizing the lipid composition in the liver of the two
different mouse groups (Table 3). As expected, the fractional
lipid mass (fLM) differed significantly between ob/ob and
ob/? mice (0.217 ± 0.013 in ob/ob vs. 0.034 ± 0.010 in
ob/? mice, P \ 0.001). A significant increase in the satu-
rated lipid component (SL) of ob/ob mice could also be
observed (9.85 ± 0.11 in ob/ob vs. 7.06 ± 0.41 in ob/?,
P \ 0.001), but not in the total unsaturated component
(ULtotal; P = 0.12). Similarly, no differences were found
between ob/ob and ob/? control mice in the fraction of
unsaturated (fUL), the fraction of saturated (fSL) and the
fraction of polyunsaturated (fPUL) lipids. However, the
fraction of monounsaturated lipids (fMUL) with only one
carbon–carbon double bond per chain was significantly
higher in ob/ob mice compared to ob/? mice. Correspond-
ingly, the ratio of polyunsaturated to monounsaturated lipids
was found significantly lower in ob/ob mice compared to
ob/? controls (0.40 ± 0.09 in ob/ob vs. 1.13 ± 0.34 in ob/?,
P = 0.026). Furthermore, an increase in the mean chain
length was observed in ob/ob mice compared to ob/? mice
(19.4 ± 0.4 in ob/ob vs. 15.8 ± 1.0 in ob/?, P = 0.003).
Discussion
1H MR spectroscopic information on hepatic lipid com-
position can be obtained in multiple ways: by collecting
Table 2 Averaged T2 values and relative intensity to water of individual lipids component and water in ob/ob and ob/? control mice at 9.4T
Peak T2 values Relative intensity to water
ob/ob ob/? P ob/ob ob/? P
Lip09 42.1 ± 3.2 25.3 ± 2.8 0.008 2.32E-02 ± 2.09E-03 3.98E-03 ± 1.33E-03 1.21E-04
Lip13 42.5 ± 3.8 53.4 ± 4.2 0.076 1.52E-01 ± 1.23E-02 1.88E-02 ± 6.36E-03 3.03E-05
Lip16 15.6 ± 1.8 21.5 ± 13.0 0.497 2.26E-02 ± 1.26E-03 3.27E-03 ± 7.48E-04 1.91E-06
Lip21 33.7 ± 3.2 30.3 ± 3.9 0.508 2.73E-02 ± 1.37E-03 3.77E-03 ± 8.90E-04 8.08E-07
Lip23 27.4 ± 3.2 26.7 ± 8.7 0.931 1.80E-02 ± 1.22E-03 2.35E-03 ± 7.10E-04 8.31E-06
Lip28 25.0 ± 1.8 21.3 ± 2.9 0.275 3.64E-03 ± 4.80E-04 1.01E-03 ± 3.68E-04 5.00E-03
Lip52&53 37.8 ± 3.6 37.3 ± 2.0 0.948 2.14E-02 ± 1.84E-03 3.17E-03 ± 1.01E-03 6.03E-05
Water 11.9 ± 1.0 14.3 ± 0.3 0.039 1
Lip41 16.5 ± 1.6 1.60E-02 ± 1.42E-03
Lip43 14.0 ± 1.2 1.54E-02 ± 2.31E-03
Shown are the mean and standard error
All the bold values are below 0.05, which means they are significant
Fig. 1 Anatomical reference images with voxel for single voxel
spectroscopy indicated (3 9 3 9 3 mm3) and spectrum from ob/ob
and ob/? mice. Resonances are labeled according to their chemical
shift values
Magn Reson Mater Phy (2012) 25:381–389 385
123
information from a single volume of interest (voxel), or in
the form of low resolution images (chemical shift imaging
or spectroscopic imaging) [21–24]. A disadvantage of the
imaging procedures is long acquisition time and the higher
complexity in deriving accurate quantification [23]. In
contrast, single voxel MRS is rather straightforward, pro-
vides high spectral resolution, which is beneficial for
deriving quantitative data. Its principal limitation is the
local information provided, which may constitute an issue
when sampling highly heterogeneous tissue.
Apart from signals of other metabolites, the liver 1H
PRESS spectra comprises contributions from mobile lipids
including mono-, di- and triacylglycerols, non-esterified
fatty acids, cholesterol, cholesterol ester [12, 20, 35]. Nine
resonances arising from molecular constituents such as
–CH3, –CH2– and –CH– groups of the lipid chains can be
typically resolved in the chemical shift range from 0.9 to
5.3 ppm (with the water reference at 4.65 ppm in LCModel).
The intensities of these individual peaks can be used to
extract detailed information on the composition of the lipids.
Differences in biophysical parameters of chemical entities
have to be accounted for when deriving quantitative data.
The relaxation behavior of tissue (lipid and water) protons
depends on their local chemical environment. Hence,
different compounds/functional groups display different
transverse and longitudinal relaxation times T1 and T2. T1
effects can be accounted for by using a long repetition delay.
Since we used TR = 6 s with T1 values of water at 9.4T being
around 2 s [34] and T1 of lipids even shorter (\1.2 s) [13,
18], we can assume that the lipid signals were almost fully
recovered ([99% recovery), while there was some remain-
ing saturation (approximately 95% recovery) for the water
signal. This will lead to a slight (less than 5%) overestimation
of the fractional lipid mass (fLM), which however is irrele-
vant in view of the changes between the two mouse strains.
However, T2 values of individual signals had to be consid-
ered in order to accurately determine even relative signal
intensities [13, 18, 34].
In our analysis, we assumed that hepatic mobile lipids
predominantly consist of saturated, mono- and
polyunsaturated compounds. Moreover, we assumed that
the distribution of lipids across the liver is homogeneous,
as liver tissue appeared homogeneous in MR images.
Previous reports confirmed a homogeneous distribution
[37]. Nevertheless, we carefully positioned the PRESS
voxel within the same anatomical location to ensure an
accurate comparison of MRS data in different animals. In
order to achieve good spectral quality, this location was
chosen in a liver region at a fair distance to the organ
margin and carefully avoiding contribution from major
liver vessels. This minimized line broadening due to sus-
ceptibility changes across different tissues.
Changes in hepatic lipid composition reflect changes in
whole body lipid metabolism [38]. It has been reported that
ob/ob mice displayed higher levels of intracellular hepatic
triglycerides as early as 2 weeks after birth [27, 28]. The
level of fractional lipid mass (fLM) in ob/ob mice found in
this study is in line with results obtained using conven-
tional techniques [28]. fLM values in ob/? controls were
slightly higher than literature values though the difference
was not significant (3.4 ± 1.0% vs. 2.7% estimated from
literature [28] assuming a mean molecular weight of tri-
glycerides of 800 Dalton). An important finding was a
significantly longer mean chain length in ob/ob as com-
pared to ob/? mice. In ob/ob mice, influx of free fatty acid
from circulation is increased [39]. Moreover, fatty acid
synthesis activity, de novo hepatic long chain fatty acid and
triglyceride synthesis are elevated, however the very low
density lipoprotein synthesis and TG export are not
increased [3, 28, 40]. In combination with impaired liver
mitochondrial b-oxidation, hepatic lipids accumulate, in
particular the long chain fatty acyl-CoA [27, 31]. This
might contribute to longer mean chain length of hepatic
lipid in ob/ob mice as compared to ob/? controls.
We also observed that the saturated lipid components
(SL) and fraction of monounsaturated lipids (fMUL) are
significantly higher in ob/ob mice compared to ob/? con-
trols. In contrast, the total unsaturated component (ULtotal),
the fraction of saturated (fSL) and unsaturated lipids (fUL),
as well as the fraction of polyunsaturated lipids (fPUL)
Table 3 Hepatic lipid level and
fat composition in ob/ob and ob/
? control mice
Shown are the mean and
standard error
All the bold values are below
0.05, which means they are
significant
Parameter ob/ob ob/? P
Fractional lipid mass (fLM) 0.217 ± 0.013 0.034 ± 0.010 1.15E206
Saturated lipid component (SL) 9.854 ± 0.106 7.060 ± 0.408 1.35E205
Total unsaturated component (ULtotal) 1.397 ± 0.063 1.210 ± 0.096 0.123
Fraction of unsaturated (fUL) 0.900 ± 0.038 0.770 ± 0.106 0.194
Fraction of saturated (fSL) 0.100 ± 0.038 0.230 ± 0.106 0.194
Fraction of polyunsaturated (fPUL) 0.248 ± 0.042 0.381 ± 0.085 0.146
Fraction of monounsaturated (fMUL) 0.652 ± 0.036 0.389 ± 0.072 0.005
fPUL/fMUL 0.398 ± 0.087 1.125 ± 0.340 0.026
Mean chain length (MCL) 19.4 ± 0.4 15.8 ± 1.0 0.003
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were not different between these two groups. Nevertheless,
taken into account the higher amount of lipids of ob/ob
mice, the concentration of unsaturated hepatic lipid is
higher in ob/ob than ob/? control mice, which might be
more relevant with regard to liver function than the actual
composition. The ratio of polyunsaturated to monounsat-
urated lipids is significantly lower in ob/ob mice than in
ob/? controls, which might indicate depletion of polyun-
saturated fatty acid in obesity-related hepatic steatosis [38].
The determination of lipid levels and composition from
1H MRS spectra raises several issues that may affect
quantification inherently:
1. Limited spectral resolution may lead to contamination
of individual lipid resonances by signal contributions
from other metabolites, which will affect the intensity
measurement [8, 11, 20].
2. Spectral dispersion translates into chemical shift
displacement, an intrinsic property of a gradient based
localization technique such as PRESS. Proportional to
the chemical shift value of a given resonance, the
selected voxel will be shifted in all three dimensions.
Hence the individual resonances are not measured
exactly at the same position. For the gradient strength
used in our experiments, the chemical shift displace-
ment between the voxel corresponding to water peak
and that of the Lip13 peak amounts to approximately
0.8 mm (for a voxel dimension of 3 mm). This might
be a potential source of error, but should not be critical
for our analysis, since we assume a homogeneous lipid
composition in the liver.
3. The result of the spectral analysis will depend on the
accuracy of the theoretical lineshape model applied. In
this study, we have applied LCModel using Lorentz-
ian–Gaussian lineshapes. The in vivo signals are the
sum of 1H spin-coupled multiplets from several
different fatty acids with slightly different chemical
shifts that cannot be resolved [20]. Consequently, a
single Lorentzian–Gaussian line will not properly
represent the experimental lineshape, which might
translate into small errors in quantification [41].
4. As already mentioned, T2 relaxation has to be adapted to
obtain comparable intensity readouts. The signals
observed in our experiments are the superposition of
multiple resonances, and therefore a single exponential
model may not be accurate. Our experimental data are not
sufficient to allow multi-exponential regression analysis,
as this would be a better way to perform the analysis.
5. Due to J-coupling T2 values obtained from PRESS
experiments are smaller than those obtained when using
the STEAM sequence [42, 43], which might affect the
accuracy of the intensity quantification. Based on
literature data [43], we estimated that the effect of
J-coupling modulation on I(0) values would be of the
order of ±10%, which would translate into correspond-
ing uncertainties regarding the parameters describing
the lipid composition The conclusion regarding these
parameters describing hepatic lipid composition is not
affected by the deviation. Statistically significant
differences between ob/ob and ob/? mice would still
be found for the parameters fLM, SL, fMUL and fPUL/
fMUL. Only for the MCL, the difference might become
non-significant in the most unfavourable case.
Some of the above mentioned drawbacks of the 1H MRS
measurements might be addressed by using proton-decou-
pled 13C MRS. This approach yields a significantly higher
spectral dispersion and therefore allows a more detailed
characterization of the fat composition [8, 14]. In fact, there
are reports demonstrating consistent results between 13C
MRS derived lipid concentrations and values obtained from
lipid extraction followed by chromatographic analysis [8].
Yet, clinical translation of such an approach is challenging:
natural abundance 13C MRS suffers from low sensitivity
and correspondingly from low spatial resolution. In addi-
tion, the large chemical shift range in 13C spectra will lead to
substantial chemical shift displacements. Both limitations
can be addressed using 1H–13C polarization transfer tech-
niques, which are technically challenging and face other
limitations [37, 38]. Moreover, 13C MRS requires a two
channel system, whereas 1H MRS experiments can be car-
ried out in principle on any clinical scanner.
The potential of the 1H MRS approach might be further
enhanced by chemical shift imaging/spectroscopic imag-
ing. This provides spatially resolved information on the
hepatic lipid distribution in two or even three dimensions,
and complements the data on lipid composition with spatial
information [23].
1H MRS has emerged as attractive tool to assess lipid
metabolism in vivo noninvasively in mice in various tissue
compartments such as adipose tissue [18], skeletal muscle
[44] and liver under normal and pathological conditions.
Due to cross-talk between adipose tissues and liver, it’s
interesting to evaluate the lipid content and composition in
adipose tissues for further study. Combining these readouts
and monitoring tissue specific lipid accumulation and
composition in a longitudinal manner in mouse models of
metabolic disorders (including genetically engineered
mice) might provide novel insights into mechanistic
aspects underlying the pathogenesis of hepatic steatosis.
Conclusion
In conclusion, we applied 1H MRS measurements at 9.4T
to assess the amount of hepatic lipids as well as the fat
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composition in ob/ob and ob/? control mice in vivo and
non-invasively from a voxel of 3 9 3 9 3 mm3. Signifi-
cant differences between these two lines have been found
for the fractional lipid mass (fLM), saturated lipid com-
ponent (SL) as well as the fraction of monounsaturated
lipids (fMUL). Moreover, the mean chain length (MCL)
and the ratio of polyunsaturated to monounsaturated lipids
(fPUL/fMUL) differ significantly. These changes reflect
alterations in the general lipid metabolism of the mice,
which is attractive given the large number of genetically
engineered mouse line available for mechanistic studies.
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